glp 1 how much weight can you lose GLP-1 Medications: Everything Need to Know The Science Behind GLP-1's: Here's

Participants lost an average of 17.1% body weight at 48 weeks

Federal Programs May Expand Access, But Timeline Is Unclear The Trump administration announced the BALANCE model in December 2025, which aims to expand access to GLP-1s in Medicare and Medicaid by negotiating lower prices with manufacturers

Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events

Moreover, the growing popularity of drugs like semaglutide and liraglutide has increased interest in their broader health impacts